GNOMvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with GNOM, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
GNOM performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 04/24/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | GNOM ETF 2 | +7.67%– | -7.03%– | +0.74%– | +41.51%– | -6.56%– | -50.60%– |
| Flows | GNOM ETF 2 | -$829K– | +$1M– | -$602K– | -$14M– | -$120M– | +$1M– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | GNOM ETF 2 | +28.47%– | +27.16%– | +28.79%– | +33.22%– |
| Max drawdown | GNOM ETF 2 | -16.08%– | -18.16%– | -46.50%– | -72.17%– |
| Max drawdown duration | GNOM ETF 2 | 88d– | 92d– | 1075d– | 1758d– |
Trading data
GNOM | ETF 2 | |
Last sale 4/27/2026 at 1:30 PM | $45.43 | – |
| Previous close 04/24/2026 | $45.97 | – |
| Consolidated volume 04/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of March 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
GNOM | ETF 2 | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 4/27/2026 at 1:30 PM
Live
Closed
GNOM | ETF 2 | |
|---|---|---|
| Last price | $45.43 | – |
| 1D performance | -1.17% | – |
| AuM | $51.60 M | – |
| E/R | 0.5% | – |
Characteristics
GNOM | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | Global X | – |
| Benchmark | Solactive Genomics Index | – |
| N° of holdings | 45 | – |
| Asset class | Equities | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 5, 2019 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
GNOM
USA
87.57%
Other
12.43%
ETF 2
Sectors
GNOM
Health Care
88.49%
Other
11.51%
ETF 2
Advertisement
Diversification
GNOM
Total weight of top 15 holdings out of 15
66.21%
ETF 2
–
Top 15 holdings
Data as of March 31, 2026
GNOM
MODERNA INC
8.48%
ARROWHEAD PHARMACEUTICALS INC
6.21%
US74006W2070
6.13%
ILLUMINA
5.52%
GUARDANT HEALTH INC
5.18%
VERTEX PHARMACEUTICALS
4.61%
BIOMARIN PHARMACEUTICAL
4.59%
NATERA
4.21%
BIO-TECHNE CORP
3.64%
BIONTECH SE ADR
3.58%
CRISPR THERAPEUTICS
3.08%
BRISTOL-MYERS SQUIBB
3.05%
ALNYLAM PHARMACEUTICALS
2.85%
TWIST BIOSCIENCE CORP
2.54%
ASTRAZENECA
2.53%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
